GENEVA, May 18 -- ETH ZURICH (Raemistrasse 1018092 Zurich) filed a patent application (PCT/EP2025/070130) for "ULK1 INHIBITOR FOR THE TREATMENT OF A NEURODEGENERATIVE DISEASE" on Jul 14, 2025. With publication no. WO/2026/098802, the details related to the patent application was published on May 15, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): GEREZ, Juan Atilio (8051 Zurich), RIEK, Roland (6060 Sarnen), PRYMACZOK, Natalia Cecilia (8051 Zurich)
Abstract: The invention relates to a ULK1 inhibitor for use in the treatment of a human or mammalian patient being diagnosed for, suffering from,...